Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04358237 |
| Title | Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer. (LUPER) |
| Acronym | LUPER |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Antonio Calles Blanco |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Hospital Vall D´Hebrón | Barcelona | Spain | Details | |||
| ICO - Instituto Catalán de Oncología | Barcelona | Spain | Details | |||
| Hospital Gregorio Marañon | Madrid | Spain | Details | |||
| START - Phase I Unit - HN San Chinarro | Madrid | Spain | Details | |||
| Start - Unidad Fase I - Fundacion Jimenez Diaz | Madrid | Spain | Details |